BICX · BioCorRx Inc.
$0.21
+0.01 (+4.48%)
At close · Aug 31
View the 10-Q filed Aug 14, 2026
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash of $21,237 and working capital deficit of $8,231,326. During the six months ended June 30, 2026, the Company used net cash in operating activities of $873,260. The Company has incurred net losses since inception. These conditions raise substantial doubt about the Company's ability to continue as a going concern for the next twelve-month period since the date of the financial statements were issued.”View the 10-Q filed Aug 14, 2026
Customer concentration
— top 2 customers 100% of revenue
2 customers — 100% of revenue (three months ended June 30, 2026)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2026 included 100% from two customers of the Company's total revenues.”
2 customers — 99% of revenue (three months ended June 30, 2025)
“The Company's revenues earned from sale of products and services for the three months ended June 30, 2025 included 99% from two customers of the Company's total revenues.”
Market Cap
$5.98M
Shares
29.76M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.21
Open$0.22
Day$0.21–0.22
52W close$0.16–0.50
Avg vol 30d6K
Short int543 · 0.0% float · 1.0d
Short vol38%
DataJan 2020–Aug 2026
Filing10-Q · Aug 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−41%
below
Price vs 50-day avg
−34%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
15%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−30%
trailing
6-month return
−29%
trailing
YTD return
−28%
this year
Relative strength
−43%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -68.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
+10301%
Y/Y
Gross margin
70%
contracting
EPS growth
+61%
Y/Y
Free cash flow
$-2.3M
Balance sheet
$68.6K
net cash
Quant / Vol
risk profile
Volatility
343%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
18.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−41%
Bearish
Price vs 50-day avg
−34%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
15%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -68.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 15%
Range high $1
vs 200-day avg -41%
vs 50-day avg -34%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BICX
this stock
BioCorRx Inc.
|
$5.98M | -27.8% | +10301.1% | — | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$91.98B | -11.4% | +7.1% | 14.3 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.36B | -9.5% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.48B | +33.8% | +0.9% | 10.3 | 3.1% |
|
FMS
Fresenius Medical Care AG
|
$12.11B | -4.5% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BICX | -16.0% | -30.0% | -29.3% | -19.2% | -27.8% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -16.5% | -31.2% | -42.6% | -21.9% | -40.3% |